Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Can dopamine agonists prevent postoperative remnant enlargement in nonfunctioning pituitary adenomas?

Nature Clinical Practice Endocrinology & Metabolism volume 2, pages 10–11 (2006)Cite this article

boxed-textGreenman Y et al. (2005) Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin Endocrinol 63: 39–44

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Bevan JS et al. (1992) Dopamine agonists and pituitary tumor shrinkage. Endocrine Rev 13: 220–240

    Article  CAS  Google Scholar 

  2. Greenman Y et al. (2003) Post-operative surveillance of clinically non-functioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol 58: 763–769

    Article  CAS  Google Scholar 

  3. Renner U et al. (1998) Heterogeneous dopamine D2 receptor subtype messenger ribonucleic acid expression in clinically non-functioning pituitary adenomas. J Clin Endocrinol Metab 83: 1368–1375

    CAS  PubMed  Google Scholar 

  4. Pivonello R et al. (2004) Dopamine receptor expression and function in clinically nonfunctioning pituitary tumors: comparison with the effectiveness of cabergoline treatment. J Clin Endocrinol Metab 89: 1674–1683

    Article  CAS  Google Scholar 

  5. Van Schaardenburg et al. (1989) Bromocriptine therapy for non-functioning pituitary adenoma. Clin Endocrinol 30: 475–484

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Vicky Heath, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Consultant Endocrinologist at the Aberdeen Royal Infirmary and an Honorary Senior Lecturer at the University of Aberdeen, UK

    John S Bevan

Authors
  1. John S Bevan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to John S Bevan.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bevan, J. Can dopamine agonists prevent postoperative remnant enlargement in nonfunctioning pituitary adenomas?. Nat Rev Endocrinol 2, 10–11 (2006). https://doi.org/10.1038/ncpendmet0049

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpendmet0049

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing